高强度聚焦超声与手术治疗症状性子宫肌瘤的meta分析
这项meta分析纳入10项研究共4450例子宫肌瘤患者,比较超声或MR引导的高强度聚焦超声(HIFU)与手术治疗症状性子宫肌瘤的疗效与安全性。结果显示HIFU在症状缓解、生活质量改善、恢复时间和严重并发症方面优于手术,而不良事件、症状复发、再干预和妊娠结局与手术相当。作者指出仍需高质量随机对照研究,尤其关注再干预率和妊娠结局。
要点
- HIFU在症状缓解、生活质量改善和恢复时间上优于手术,严重并发症更少。
- HIFU与手术在不良事件、复发、再干预和妊娠率上无统计学差异。
- 证据质量有限,再干预率和妊娠结局需进一步随机研究验证。
核心结论
- HIFU在症状缓解、生活质量改善、恢复及严重并发症方面优于手术,在不良事件、复发、再干预和妊娠方面与手术相当。
研究设计与样本
- 系统综述与meta分析,检索2000年1月至2020年7月多个数据库中比较HIFU与手术治疗子宫肌瘤的研究。
- 纳入10项研究,共4450例女性,合并均数差(MD)或相对危险度(RR)及95%置信区间(CI)。
诊断标准与关键数值
- HIFU组6个月和12个月子宫肌瘤严重程度评分下降均优于手术组(MD -4.16,95%CI -7.39至-0.94;MD -2.44,95%CI -3.67至-1.20,p<0.05)。
- HIFU组6个月和12个月生活质量评分提升均优于手术组(MD 2.13,95%CI 0.86至3.14;MD 2.34,95%CI 0.82至3.85,p<0.05)。
- HIFU组住院时间和恢复工作时间更短(MD -3.41天,95%CI -5.11至-1.70;MD -11.61天,95%CI -19.73至-3.50,p<0.05)。
- HIFU组严重并发症发生率更低(RR 0.33,95%CI 0.13至0.81,p<0.05)。
- 不良事件、症状复发、再干预和妊娠结局在两组间差异无统计学意义(p>0.05)。
临床应用与阅片要点
- 对于症状性子宫肌瘤患者,HIFU可作为手术之外的非侵入性治疗选择,尤其适合希望缩短恢复时间、降低严重并发症风险者。
- 阅片时需评估肌瘤的位置、大小、血供及与周围结构的关系,以判断HIFU治疗的适宜性;术后影像随访注意有无复发或再干预需求。
局限性
- 缺乏高质量对比数据,尤其再干预率和妊娠结局方面需进一步随机对照研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the treatment success and safety of ultrasound- and MR-guided high-intensity focused ultrasound (HIFU) with surgery for treating symptomatic uterine fibroids.
METHODS: We searched studies comparing HIFU with surgery for fibroids in different databases from January 2000 to July 2020. The mean difference (MD) or relative risk (RR) with 95% confidence interval (CI) for different outcome parameters was synthesized.
RESULTS: We included 10 studies involving 4450 women. Compared with the surgery group, the decrease in uterine fibroid severity score at 6- and 12-month follow-up was higher in the HIFU group (MD - 4.16, 95% CI - 7.39 to - 0.94, and MD - 2.44, 95% CI - 3.67 to - 1.20, p < 0.05). The increase in quality-of-life (QoL) score at 6- and 12-month follow-up was higher in the HIFU group (MD 2.13, 95% CI 0.86 to 3.14, and MD 2.34, 95% CI 0.82 to 3.85, p < 0.05). The duration of hospital stay and the time to return to work was shorter in the HIFU group (MD - 3.41 days, 95% CI - 5.11 to - 1.70, and MD - 11.61 days, 95% CI - 19.73 to - 3.50, p < 0.05). The incidence of significant complications was lower in the HIFU group (RR 0.33, 95% CI 0.13 to 0.81, p < 0.05). The differences in the outcomes of adverse events, symptom recurrence, re-intervention, and pregnancy were not statistically significant (p > 0.05).
CONCLUSIONS: HIFU is superior to surgery in terms of symptomatic relief, improvement in QoL, recovery, and significant complications. However, HIFU showed comparable effects to surgery regarding the incidence of adverse events, symptom recurrence, re-intervention, and pregnancy.
KEY POINTS: • HIFU ablation is superior to surgery in terms of symptomatic relief, improvement in QoL, recovery, and significant complications. • HIFU has comparable effects to surgery in terms of symptom recurrence rate, re-intervention rate, and pregnancy rate, indicating that HIFU is a promising non-invasive therapy that seems not to raise the risk of recurrence and re-intervention or deteriorate fertility compared to surgical approaches in women with fibroids. • There is still a lack of good-quality comparative data and further randomized studies are necessary to provide sufficient and reliable data, especially on re-intervention rate and pregnancy outcome.
引用
- Liu L, Wang T, Lei B, et al. High-intensity focused ultrasound (HIFU) ablation versus surgical interventions for the treatment of symptomatic uterine fibroids: a meta-analysis. Eur Radiol. 2021. PMID: 34333684. doi:10.1007/s00330-021-08156-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。